Back to VOLORIDGE INVESTMENT MANAGEMENT, LLC VOLORIDGE INVESTMENT MANAGEMENT, LLC

REGNREGN
Showing 7 of 24 quarters

Position history for VOLORIDGE INVESTMENT MANAGEMENT, LLCVOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in REGENERON PHARMACEUTICALS

VOLORIDGE INVESTMENT MANAGEMENT, LLC holds 163,963 shares of REGN (REGENERON PHARMACEUTICALS), worth $102.2M as of 2026-Q2. The position was increased (+967.2% shares). REGN represents 0.4% of VOLORIDGE INVESTMENT MANAGEMENT, LLC's portfolio.

Current Value

$102.2M

Current Shares

163,963

Total Value Change

-$48.9M

Total Shares Change

-48,165

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
163,963
+967.2%
$102.2M0.4%$623.54
58
2026-Q1
New
15,364
-
$11.9M0.0%$766.66
39
2025-Q4
Exited
0
-100.0%
$00.0%$773.94
0
2025-Q3
Decreased
172,836
-38.2%
$97.2M0.3%$560.05
0
2025-Q2
Increased
279,860
+22.6%
$146.9M0.5%$519.56
52
2025-Q1
Increased
228,270
+7.6%
$144.8M0.5%$634.66
46
2024-Q4
New
212,128
-
$151.1M0.5%$698.71
59

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used